Related references
Note: Only part of the references are listed.SIRT2 mediates multidrug resistance in acute myelogenous leukemia cells via ERK1/2 signaling pathway
Hua Xu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity
Asad Ali Shah et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2016)
SIRT2 is an unfavorable prognostic biomarker in patients with acute myeloid leukemia
Ailing Deng et al.
SCIENTIFIC REPORTS (2016)
Treatment and survival among 1594 patients with ATL
Hiroo Katsuya et al.
BLOOD (2015)
Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism
Pedro Gomes et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Novel small-molecule SIRT1 inhibitors induce cell death in adult T-cell leukaemia cells
Tomohiro Kozako et al.
SCIENTIFIC REPORTS (2015)
Historical landmarks of autophagy research
Yoshinori Ohsumi
CELL RESEARCH (2014)
SIRT2: Tumour suppressor or tumour promoter in operable breast cancer?
Liane M. McGlynn et al.
EUROPEAN JOURNAL OF CANCER (2014)
SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors
Toshiaki Inoue et al.
FEBS JOURNAL (2014)
A Novel Sirtuin 2 ( SIRT2) Inhibitor with p53-dependent Pro- apoptotic Activity in Non- small Cell Lung Cancer*
Gesine Hoffmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy
M. V. Stankov et al.
LEUKEMIA (2014)
Anticancer Agents Targeted to Sirtuins
Tomohiro Kozako et al.
MOLECULES (2014)
A novel image-based cytometry method for autophagy detection in living cells
Leo Li-Ying Chan et al.
AUTOPHAGY (2012)
SIRT2 activity is required for the survival of C6 glioma cells
Xin He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
High expression of the longevity gene product SIRT1 and apoptosis induction by sirtinol in adult T-cell leukemia cells
Tomohiro Kozako et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Design, Synthesis, and Biological Activity of a Novel Series of Human Sirtuin-2-Selective Inhibitors
Takayoshi Suzuki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition
Jiyeong Gal et al.
NEUROCHEMISTRY INTERNATIONAL (2012)
SIRT2 Maintains Genome Integrity and Suppresses Tumorigenesis through Regulating APC/C Activity
Hyun-Seok Kim et al.
CANCER CELL (2011)
Oligomannose-coated liposomes efficiently induce human T-cell leukemia virus-1-specific cytotoxic T lymphocytes without adjuvant
Tomohiro Kozako et al.
FEBS JOURNAL (2011)
SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis
Yanze Li et al.
GENES TO CELLS (2011)
Autophagy and apoptosis: what is the connection?
Jacob M. Gump et al.
TRENDS IN CELL BIOLOGY (2011)
Mitochondria and cell death: outer membrane permeabilization and beyond
Stephen W. G. Tait et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Design, synthesis, enzyme inhibition, and tumor cell growth inhibition of 2-anilinobenzamide derivatives as SIRT1 inhibitors
Takayoshi Suzuki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia
Tomohiro Kozako et al.
MOLECULAR IMMUNOLOGY (2009)
PD-1/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia/lymphoma patients
T. Kozako et al.
LEUKEMIA (2009)
p53 activation: A case against sir
Christopher L. Brooks et al.
CANCER CELL (2008)
Caspase-independent cell death: leaving the set without the final cut
S. W. G. Tait et al.
ONCOGENE (2008)
VCAP-AMP-VECP compared with biweekly CHOP for adult T-Cell leukemia-lymphoma: Japan clinical oncology group study JCOG9801
Kunihiro Tsukasaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Human T-lymphotropic virus 1: recent knowledge about an ancient infection
Kristien Verdonck et al.
LANCET INFECTIOUS DISEASES (2007)
Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation
Masao Matsuoka et al.
NATURE REVIEWS CANCER (2007)
Reduced frequency, diversity, and function of human T cell leukemia virus type 1-specific CD8+ T cell in adult T cell leukemia patients
Tomohiro Kozako et al.
JOURNAL OF IMMUNOLOGY (2006)
Natural history of adult T-cell leukemia/lymphoma and approaches to therapy
GP Taylor et al.
ONCOGENE (2005)
Caspase-independent cell death
G Kroemer et al.
NATURE MEDICINE (2005)
Role of NAD-dependent deacetylases SIRT1 and SIRT2 in radiation and cisplatin-induced cell death in vertebrate cells
N Matsushita et al.
GENES TO CELLS (2005)
Development by self-digestion: Molecular mechanisms and biological functions of autophagy
B Levine et al.
DEVELOPMENTAL CELL (2004)
HTLV-1 tax protein inhibits apoptosis induction but not G1 arrest by pyrrolidinedithiocarbamate, an anti-oxidant, in adult T cell leukemia cells
N Arima et al.
EXPERIMENTAL HEMATOLOGY (2004)
Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle
SC Dryden et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Mitochondrial reactive oxygen species in cell death signaling
C Fleury et al.
BIOCHIMIE (2002)
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303
Y Yamada et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Cell biology - Autophagy as a regulated pathway of cellular degradation
DJ Klionsky et al.
SCIENCE (2000)
The silencing protein SIR2 and its homologs are MAD-dependent protein deacetylases
J Landry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
